Norway· NO-ID_EA025239-1086-4B97-93B0-215C5FEFDF83
Quinidine Sulfate epic
A quinidine product containing kinidin, registered in Norway by Epic Pharma. The same ATC class is registered in 6 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Quinidine is registered in 6 of 19 countries.
Countries holding a registration under ATC C01BA01 (quinidine), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 3 of them publish a price we can compare per daily dose
Quinidine · ATC C01BA01
6 / 19 countries
- Finlandprice
- Japan
- Netherlands
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Kinidin
- Manufacturer
- Epic Pharma
- Country
- Norway (NO)
- ATC code
- C01BA01
- ATC class
- Quinidine
- Defined daily dose
- 1.2 g, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
- no_merkevare_idID_EA025239-1086-4B97-93B0-215C5FEFDF83
- no_varenummer27181430
- gtin342806513309
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
491 interactions on record for quinidine.
Graded by severity as the source publishes them — 135 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Quinidine · interactions on record
491 records
- 135 severe
- 198 moderate
- 8 minor
- 108 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
42 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Quinidine in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomQuinidine sulfate 200mg tabletsSpecial Order
- United StatesQUINIDINE SULFATEEPIC PHARMA, LLC
- FinlandChinidini SulfasOrion Corporation Orion Pharma
- Japanキニジン硫酸塩水和物
- BelgiumNuedexta 15 mg - 9 mgJenson Pharmaceutical Services
- NetherlandsKinidinesulfaat Teva 200 mg, drageesTeva Nederland B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Hungary · Chinidin-Wagner
- Netherlands · Kinidinesulfaat Teva
- Romania · Chinidina
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/75687f91-593a-48b9-8d12-b6b39b9bf0e8 GET /v1/drugs/75687f91-593a-48b9-8d12-b6b39b9bf0e8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablett",
"source": "fest",
"status": "A",
"atc_name": "Kinidin",
"merkevare_id": "ID_EA025239-1086-4B97-93B0-215C5FEFDF83",
"name_form_strength": "Quinidine Sulfate epic tab 200 mg",
"prescription_group": "C"
}See everything about quinidine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.